West Pharmaceutical (WST) Tops Q4 EPS by 5c; Issues Strong FY13 Outlook

February 21, 2013 7:27 AM

West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.61, $0.05 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found